By Charles Dunham, IV, Shareholder at Greenberg Traurig, LLP & Benjamin Nipper, Associate at Greenberg Traurig, LLP In January 2020, the U.S. Department of Justice (DOJ) made its first … [Read more...]
EKRA: More than a Year Out, Major Questions Remain Unresolved
January 26, 2020
One of the scariest new lab compliance laws in recent memory is the Eliminating Kickbacks in Recovery Act of 2018 (EKRA). While laws banning remuneration in exchange for referrals is nothing new to … [Read more...]
EKRA
EKRA: More than a Year Out, Major Questions Remain Unresolved
January 2, 2020
One of the scariest new lab compliance laws in recent memory is the Eliminating Kickbacks in Recovery Act of 2018 (EKRA). While laws banning remuneration in exchange for referrals is nothing new to … [Read more...]
COMPLIANCE
Sales & Marketing: The Perils of Restructuring Sales Commissions for EKRA
January 2, 2020
For many years, it was fairly common practice for labs to pay their sales representatives variable compensation based on the volume and value of the tests they generated. But those arrangements became … [Read more...]
FALSE CLAIMS
Compliance Perspectives: How to Spot & Avoid Kickback Risks under New EKRA Law
April 1, 2019
A new law passed to deal with the opioid epidemic has significant ramifications for labs including but not limited to those involved in drug addiction and recovery programs. Specifically, the … [Read more...]
LEGISLATION
New Broad All-Payor Kickback Law Impacting Laboratories, Commission-based Compensation and more
January 14, 2019
By Danielle Sloane bio and Chris Climo bio In a recent piece of federal legislation intended to address the opioid crisis across the United States, Congress enacted a new all-payor kickback … [Read more...]
